
At Astellas, we know that diversity in clinical trials is essential for advancing healthcare and making sure everyone benefits from medical innovations. We are committed to fostering an inclusive environment that reflects the diverse communities we serve.
To do this, we are committed to:
1
Engage Diverse Populations
Actively seek to include people from different racial, ethnic, gender, age and socioeconomic backgrounds in our clinical trials to make sure the results apply to all
2
Implement Inclusive Practices
Design our clinical trials to be accessible, culturally sensitive, and supportive to make participation easier
3
Work with Communities
Partner with community groups, healthcare providers and patient advocacy organizations to raise awareness about clinical trials, address barriers to participation, and build trust with patients and caregivers
4
Educate and Train Staff
Train our teams on the importance of diversity and equip them with the tools to engage and include everyone effectively
5
Advocate for Change
Join industry-wide efforts to remove barriers and make it easier to take part in clinical trials
By committing to these principles, we aim to enhance the quality and relevance of our clinical research, ultimately leading to better health outcomes for everyone.
The importance of diversity in clinical trials

Looking back through the history of clinical research, women, people of different racial and ethnic groups, and older adults were underrepresented. Sometimes, these groups were left out completely.
Additional efforts to improve diversity in clinical trials
There are other important measures being taken to increase diversity and ensure scientifically representative clinical research. These include:
1
1990
2
Mid 1990s
National Institutes of Health (NIH) requirement that clinical trials include racial and ethnic minorities, women and individuals of all ages
3
Mid 2010-2020 to Present
Study sponsors voluntarily providing data to help the FDA track the participation rates of females, males, children, the elderly, and different underrepresented groups
4
Est 2021
United Kingdom’s NHS Race and Health Observatory initiative that investigates and addresses race inequality in medicine
5
Early 2000s to Present
Food and Drug Administration (FDA) regulations and guidance to ensure diverse inclusion in clinical trials
6
2020 to Present
Industry-wide initiatives, such as PhRMA’s Equity Initiative in the United States
7
Present Time
Additional Resources
1
Resource
Learn more about PhRMA’s industry initiatives to enhance diversity in clinical trials
2
Resource
Learn more about diversity in a clinical trials topics from the Center for Information and Study on Clinical Research Participation (CISCRP).
Find an Astellas Clinical Trial Near You
Search Astellas Clinical Trials to see if any might be a match for you or for someone you care about.
For Your Information
THE PURPOSE OF THIS WEBSITE IS TO OFFER EDUCATION AND INFORMATION TO PATIENTS AND THEIR FAMILIES AND FRIENDS, THE PUBLIC, AND HEALTHCARE PROFESSIONALS ABOUT THE CLINICAL TRIAL PROCESS. IN ADDITION, THE WEBSITE WILL PROVIDE SPECIFIC INFORMATION ABOUT ASTELLAS CLINICAL TRIALS. PLEASE READ THE COMPLETE ASTELLAS TRANSPARENCY POLICY TO LEARN ABOUT THE CLINICAL TRIAL INFORMATION AVAILABLE ON THIS WEBSITE